Combinatorial effect of radium-223 and irreversible electroporation on prostate cancer bone metastasis in mice

References

• Bubendorf L, Schöpfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31(5):578–583.
   PubMed Web of Science ®Google Scholar
• DePuy V, Anstrom KJ, Castel LD, et al. Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer. Support Care Cancer. 2007;15(7):869–876.
   PubMed Web of Science ®Google Scholar
• Janjan NA, Payne R, Gillis T, et al. Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases. J Pain Symptom Manage. 1998;16(3):171–178.
   PubMed Web of Science ®Google Scholar
• Rustøen T, Moum T, Padilla G, et al. Predictors of quality of life in oncology outpatients with pain from bone metastasis. J Pain Symptom Manage. 2005;30(3):234–242.
   PubMed Web of Science ®Google Scholar
• Coleman R, Brown J, Terpos E, et al. Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions. Cancer Treat Rev. 2008;34(7):629–639.
   PubMed Web of Science ®Google Scholar
• Jehn CF, Diel IJ, Overkamp F, et al. Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment. Anticancer Res. 2016;36(6):2631–2637.
   PubMed Web of Science ®Google Scholar
• Wu JS-Y, Wong R, Johnston M, et al.; Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003;55(3):594–605.
   PubMed Web of Science ®Google Scholar
• Agarwal MG, Nayak P. Management of skeletal metastases: An orthopaedic surgeon's guide. Indian J Orthop. 2015;49(1):83–100.
   PubMed Web of Science ®Google Scholar
• Foster RC, Stavas JM. Bone and soft tissue ablation. Semin Intervent Radiol. 2014;31(2):167–179.
   PubMed Web of Science ®Google Scholar
• Kurup AN, Morris JM, Callstrom MR. Ablation of musculoskeletal metastases. AJR Am J Roentgenol. 2017;209(4):713–721.
   PubMed Web of Science ®Google Scholar
• Erie AJ, Morris JM, Welch BT, et al. Retrospective review of percutaneous image-guided ablation of oligometastatic prostate cancer: a single-institution experience. J Vasc Interv Radiol. 2017;28(7):987–992.
   PubMed Web of Science ®Google Scholar
• McMenomy BP, Kurup AN, Johnson GB, et al. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission. J Vasc Interv Radiol. 2013;24(2):207–213.
   PubMed Web of Science ®Google Scholar
• Knavel EM, Brace CL. Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol. 2013;16(4):192–200.
   PubMedGoogle Scholar
• Vroomen LGPH, Petre EN, Cornelis FH, et al. Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences? Diagn Interv Imaging. 2017;98(9):609–617.
   PubMed Web of Science ®Google Scholar
• Tomasian A, Jennings JW. Percutaneous minimally invasive thermal ablation of osseous metastases: evidence-based practice guidelines. AJR Am J Roentgenol. 2020;215(2):502–510.
   PubMed Web of Science ®Google Scholar
• Pillai K, Akhter J, Chua TC, et al. Heat Sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model. Medicine. 2015;94(9):e580.
   PubMed Web of Science ®Google Scholar
• Maor E, Ivorra A, Rubinsky B. Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablation. PLoS ONE. 2009;4(3):e4757.
   PubMed Web of Science ®Google Scholar
• Davalos RV, Mir IL, and, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223–231.
   PubMed Web of Science ®Google Scholar
• Faroja M, Ahmed M, Appelbaum L, et al. Irreversible electroporation ablation: is all the damage nonthermal? Radiology. 2013;266(2):462–470.
   PubMed Web of Science ®Google Scholar
• Melancon MP, Appleton Figueira T, Fuentes DT, et al. Development of an electroporation and nanoparticle-based therapeutic platform for bone metastases. Radiology. 2018;286(1):149–157.
   PubMed Web of Science ®Google Scholar
• Tam AL, Abdelsalam ME, Gagea M, et al. Irreversible electroporation of the lumbar vertebrae in a porcine model: is there clinical-pathologic evidence of neural toxicity? Radiology. 2014;272(3):709–719.
   PubMed Web of Science ®Google Scholar
• Blazevski A, Scheltema MJ, Amin A, et al. Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment. BJU Int. 2020;125(3):369–378.
   PubMed Web of Science ®Google Scholar
• Edd JF, Horowitz L, Davalos RV, et al. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng. 2006;53(7):1409–1415.
   PubMed Web of Science ®Google Scholar
• Vogel JA, van Veldhuisen E, Agnass P, et al. Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies. PLoS One. 2016;11(11):e0166987.
   PubMed Web of Science ®Google Scholar
• van den Bos W, Scheffer HJ, Vogel JA, et al. Thermal energy during irreversible electroporation and the influence of different ablation parameters. J Vasc Interv Radiol. 2016;27(3):433–443.
   PubMed Web of Science ®Google Scholar
• Wagstaff PGK, de Bruin DM, van den Bos W, et al. Irreversible electroporation of the porcine kidney: Temperature development and distribution. Urol Oncol. 2015;33(4):168.e1–168.e7.
   Web of Science ®Google Scholar
• Agnass P, van Veldhuisen E, van Gemert MJC, et al. Mathematical modeling of the thermal effects of irreversible electroporation for in vitro, in vivo, and clinical use: a systematic review. Int J Hyperthermia. 2020;37(1):486–505.
   PubMed Web of Science ®Google Scholar
• Miklavcic D, Davalos RV. Electrochemotherapy (ECT) and irreversible electroporation (IRE) -advanced techniques for treating deep-seated tumors based on electroporation. BioMed Eng Online. 2015;14(Suppl 3):I1.
   PubMed Web of Science ®Google Scholar
• Dodd GD, Frank MS, Aribandi M, 3rd, et al. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol. 2001;177(4):777–782.
   PubMed Web of Science ®Google Scholar
• Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97(5):1253–1262.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Ierace T, Tonolini M, et al. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound. 2001;13(2):149–158.
   PubMedGoogle Scholar
• Bang HJ, Littrup PJ, Currier BP, et al. Percutaneous cryoablation of metastatic lesions from colorectal cancer: efficacy and feasibility with survival and cost-effectiveness observations. ISRN Minim Invasive Surg. 2012;2012:1–10.
   Google Scholar
• Bang HJ, Littrup PJ, Goodrich DJ, et al. Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation. J Vasc Interv Radiol. 2012;23(6):770–777.
   PubMed Web of Science ®Google Scholar
• Welch BT, Callstrom MR, Morris JM, et al. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma. J Urol. 2014;192(2):357–363.
   PubMed Web of Science ®Google Scholar
• White ML, Atwell TD, Kurup AN, et al. Recurrence and survival outcomes after percutaneous thermal ablation of oligometastatic melanoma. Mayo Clin Proc. 2016;91(3):288–296.
   PubMed Web of Science ®Google Scholar
• Logothetis CJ, Lin SH. Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer. 2005;5(1):21–28.
   PubMed Web of Science ®Google Scholar
• Lin S-C, Lee Y-C, Yu G, et al. Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer. Dev Cell. 2017;41(5):467–480.e3.
   PubMed Web of Science ®Google Scholar
• Lee Y-C, Lin S-C, Yu G, et al. Identification of bone-derived factors conferring de novo therapeutic resistance in metastatic prostate cancer. Cancer Res. 2015;75(22):4949–4959.
   PubMed Web of Science ®Google Scholar
• Bilen MA, Johnson MM, Mathew P, et al. Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer. Cancer. 2015;121(1):69–76.
   PubMed Web of Science ®Google Scholar
• Parker C, Nilsson S, Heinrich D, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213–223.
   PubMed Web of Science ®Google Scholar
• Deshayes E, Roumiguie M, Thibault C, et al. Radium 223 dichloride for prostate cancer treatment. Drug Des Devel Ther. 2017;11:2643–2651.
   PubMed Web of Science ®Google Scholar
• Lassmann M, Nosske D. Dosimetry of 223Ra-chloride: dose to normal organs and tissues. Eur J Nucl Med Mol Imaging. 2013;40(2):207–212.
   PubMed Web of Science ®Google Scholar
• Henriksen G, et al. Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine. 2003;44(2):252–259.
   PubMed Web of Science ®Google Scholar
• Bruland ØS, Nilsson S, Fisher DR, et al. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities? Clin Cancer Res. 2006;12(20 Pt 2):6250s–6257s.
   PubMed Web of Science ®Google Scholar
• Ritter MA, Cleaver JE, Tobias CA. High-LET radiations induce a large proportion of non-rejoining DNA breaks. Nature. 1977;266(5603):653–655.
   PubMed Web of Science ®Google Scholar
• Lin S-C, Yu-Lee L-Y, Lin S-H. Osteoblastic factors in prostate cancer bone metastasis. Curr Osteoporos Rep. 2018;16(6):642–647.
   PubMed Web of Science ®Google Scholar
• Callstrom MR, Dupuy DE, Solomon SB, et al. Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer. 2013;119(5):1033–1041.
   PubMed Web of Science ®Google Scholar
• Dupuy DE, Hong R, Oliver B, et al. Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal. AJR Am J Roentgenol. 2000;175(5):1263–1266.
   PubMed Web of Science ®Google Scholar
• Lee EW, Chen C, Prieto VE, et al. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology. 2010;255(2):426–433.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Lee YH, Jung K-J, et al. Pseudohypertrophy of the calf muscles in a patient with diabetic neuropathy: a case report. J Korean Radiol Soc. 2007;57(3):287–289.
   Google Scholar
• Li W, Fan Q, Ji Z, et al. The effects of irreversible electroporation (IRE) on nerves. PLOS One. 2011;6(4):e18831.
   PubMed Web of Science ®Google Scholar
• Fesmire CC, Petrella RA, Fogle CA, et al. Temperature dependence of high frequency irreversible electroporation evaluated in a 3D tumor model. Ann Biomed Eng. 2020;48(8):2233–2246.
   PubMed Web of Science ®Google Scholar
• Edelblute CM, Hornef J, Burcus NI, et al. Controllable moderate heating enhances the therapeutic efficacy of irreversible electroporation for pancreatic cancer. Sci Rep. 2017;7(1):11767.
   PubMed Web of Science ®Google Scholar
• Song J, Joshi RP, Schoenbach KH. Synergistic effects of local temperature enhancements on cellular responses in the context of high-intensity, ultrashort electric pulses. Med Biol Eng Comput. 2011;49(6):713–718.
   PubMed Web of Science ®Google Scholar
• Fini M, Salamanna F, Parrilli A, et al. Electrochemotherapy is effective in the treatment of rat bone metastases. Clin Exp Metastasis. 2013;30(8):1033–1045.
   PubMed Web of Science ®Google Scholar
• Tian L, Qiao Y, Lee P, et al. Antitumor efficacy of liposome-encapsulated NVP-BEZ 235 in combination with irreversible electroporation. Drug Deliv. 2018;25(1):668–678.
   PubMed Web of Science ®Google Scholar
• Tian L, Wang L, Qiao Y, et al. Antitumor efficacy of liposome-encapsulated NVP-BEZ235 Combined with Irreversible electroporation for head and neck cancer. Molecules. 2019;24(19):3560.
   Web of Science ®Google Scholar
• Zhao J, Qiao J, Zhou M, et al. Anti-tumor efficacy study using irreversible electroporation and doxorubicin-loaded polymeric micelles. ACS Macro Lett. 2015;4(10):1081–1084.
   PubMed Web of Science ®Google Scholar
• Zhao J, Wen X, Tian L, et al. Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer. Nat Commun. 2019;10(1):899.
   PubMed Web of Science ®Google Scholar
• Langan RC, Goldman DA, D'Angelica MI, et al. Recurrence patterns following irreversible electroporation for hepatic malignancies. J Surg Oncol. 2017;115(6):704–710.
   PubMed Web of Science ®Google Scholar
• Philips P, Hays D, Martin RCG. Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated. PLoS ONE. 2013;8(11):e76260.
   PubMed Web of Science ®Google Scholar
• Stillstrom D, et al. Initial experience with irreversible electroporation of liver tumours. Eur J Radiol Open. 2019;6:62–67.
   PubMed Web of Science ®Google Scholar
• Cannon R, Ellis S, Hayes D, et al. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol. 2013;107(5):544–549.
   PubMed Web of Science ®Google Scholar
• Golberg A, Bruinsma BG, Uygun BE, et al. Tissue heterogeneity in structure and conductivity contribute to cell survival during irreversible electroporation ablation by "electric field sinks. Sci Rep. 2015;5(1):8485.
   PubMed Web of Science ®Google Scholar
• Engström PE, et al. Electrically mediated drug delivery for treatment of an adenocarcinoma transplanted into rat liver. Anticancer Res. 2001;21(3b):1817–1822.
   PubMed Web of Science ®Google Scholar
• Jaroszeski MJ, Coppola D, Pottinger C, et al. Treatment of hepatocellular carcinoma in a rat model using electrochemotherapy. Eur J Cancer. 2001;37(3):422–430.
   PubMed Web of Science ®Google Scholar
• Kitamura A. Bleomycin-mediated electrochemotherapy in mouse NR-S1 carcinoma. Cancer Chemother Pharmacol. 2003;51(4):359–362.
   PubMed Web of Science ®Google Scholar
• Mir LM, Orlowski S, Belehradek J, et al. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer. 1991;27(1):68–72.
   PubMed Web of Science ®Google Scholar
• Soden DM, Larkin JO, Collins CG, et al. Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours. Cancer Lett. 2006;232(2):300–310.
   PubMed Web of Science ®Google Scholar
• Zheng MH. Effects and possible anti-tumor immunity of electrochemotherapy with bleomycin on human colon cancer xenografts in nude mice. WJG. 2005;11(16):2426–2430.
   PubMed Web of Science ®Google Scholar
• Logothetis C, Morris MJ, Den R, et al. Current perspectives on bone metastases in castrate-resistant prostate cancer. Cancer Metastasis Rev. 2018;37(1):189–196.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration, Highlights of Prescribing information for Xofigo (radium Ra 223 dichloride) Injection for intravenous use. 2013.
   Google Scholar
• Abou DS, Ulmert D, Doucet M, et al. Whole-body and microenvironmental localization of radium-223 in naïve and mouse models of prostate cancer metastasis. JNCIJ. 2016;108(5):djv380.
   PubMed Web of Science ®Google Scholar
• Suominen MI, Fagerlund KM, Rissanen JP, et al. Radium-223 inhibits osseous prostate cancer growth by dual targeting of cancer cells and bone microenvironment in mouse models. Clin Cancer Res. 2017;23(15):4335–4346.
   PubMed Web of Science ®Google Scholar
• Morris MJ, Corey E, Guise TA, et al. Radium-223 mechanism of action: implications for use in treatment combinations. Nat Rev Urol. 2019;16(12):745–756.
   PubMed Web of Science ®Google Scholar
• Rols M-P. Electropermeabilization, a physical method for the delivery of therapeutic molecules into cells. Biochim Biophys Acta. 2006;1758(3):423–428.
   PubMed Web of Science ®Google Scholar
• Vogel JA, van Veldhuisen E, Alles LK, et al. Time-dependent impact of irreversible electroporation on pathology and ablation size in the porcine liver: a 24-hour experimental study. Technol Cancer Res Treat. 2019;18:1533033819876899.
   Web of Science ®Google Scholar
• Golberg A, Khan S, Belov V, et al. Skin rejuvenation with non-invasive pulsed electric fields. Sci Rep. 2015;5:10187–10187.
   PubMed Web of Science ®Google Scholar
• Golberg A, Villiger M, Felix Broelsch G, et al. Skin regeneration with all accessory organs following ablation with irreversible electroporation. J Tissue Eng Regen Med. 2018;12(1):98–113.
   PubMed Web of Science ®Google Scholar
• Golberg A, Villiger M, Khan S, et al. Preventing Scars after Injury with Partial Irreversible Electroporation. J Invest Dermatol. 2016;136(11):2297–2304.
   PubMed Web of Science ®Google Scholar
• Marignol L, Coffey M, Lawler M, et al. Hypoxia in prostate cancer: a powerful shield against tumour destruction? Cancer Treatment Reviews. 2008;34(4):313–327.
   PubMed Web of Science ®Google Scholar
• Euhus DM, Hudd C, LaRegina MC, et al. Tumor measurement in the nude mouse. J Surg Oncol. 1986;31(4):229–234.
   PubMed Web of Science ®Google Scholar
• Milross CG, Tucker SL, Mason KA, et al. The effect of tumor size on necrosis and polarographically measured pO2. Acta Oncologica. 1997;36(2):183–189.
   PubMed Web of Science ®Google Scholar
• DiPietro LA. Angiogenesis and scar formation in healing wounds. Curr Opin Rheumatol. 2013;25(1):87–91.
   PubMed Web of Science ®Google Scholar
• Wong VW, Rustad KC, Akaishi S, et al. Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. Nat Med. 2011;18(1):148–152.
   PubMed Web of Science ®Google Scholar
• Hotker AM, et al. Temporal changes in MRI appearance of the prostate after focal ablation. Abdom Radiol. 2019;44(1):272–278.
   PubMed Web of Science ®Google Scholar